101 results
Page 4 of 6
6-K
EX-99.1
h76i0 s7p182e
25 Mar 21
Galapagos appoints Bart Filius as President and Chief Operating Officer
6:00am
6-K
EX-99.1
shr4k9u36wkcps2u
19 Feb 21
Pipeline and capital for growth
6:00am
6-K
EX-99.1
uiwpdcj3
5 Jan 21
Selvita completes acquisition of Fidelta from Galapagos
7:00am
6-K
EX-99.1
g4jb3jr
15 Dec 20
Current report (foreign)
4:55pm
6-K
EX-99.1
f4zdm6km026f8y sru4
24 Nov 20
Selvita to acquire Fidelta from Galapagos
7:05am
6-K
EX-99.1
rhv odhfjsa25
9 Nov 20
Galapagos reports Q3 2020 results
4:01pm
6-K
EX-99.2
k3fm eyllk9glbd9g
9 Nov 20
Galapagos reports Q3 2020 results
4:01pm
6-K
EX-99.1
9tcl7qc8rnthkr lb64
27 Oct 20
Current report (foreign)
12:13pm
6-K
EX-99.1
m3j5imvkpvfi5p3 zi
15 Oct 20
Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
5:27pm
6-K
EX-99.1
brnu0ul63ez4v 0jaox9
6 Aug 20
Galapagos reports solid H1 2020 progress
4:01pm
6-K
EX-99.2
fcnrrysl
6 Aug 20
Galapagos reports solid H1 2020 progress
4:01pm
6-K
EX-99.2
uza9p1417
11 May 20
Current report (foreign)
4:05pm
6-K
EX-99.1
c27tn0yta
11 May 20
Current report (foreign)
4:05pm
6-K
EX-99.9
05o1423kfgv5qtgr2ap
27 Mar 20
Publication of the annual report and invitation to the The annual report for the financial year 2019, including a review of figures and performance, is available online at
4:49pm
6-K
EX-99.1
ap731u
29 Jan 20
Current report (foreign)
6:05am
6-K
EX-99.1
eq3lx0aa qvq5hq
24 Jan 20
Galapagos appoints Michele Manto as Chief Commercial Officer
8:52am
6-K
EX-99.1
71blwvtp8uwfpp3q
9 Dec 19
Galapagos completes recruitment of NOVESA trial in systemic sclerosis
10:11am
6-K
EX-99.2
yq3pt13ufap1oge
25 Oct 19
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
5:00pm